Percy Luu

A neuroscientist by training, Percy has also had extensive industry experience working in assay development and drug screening for the biotechnology company Tularik and as a portfolio manager, advisor and technical consultant for biomedical startups Clearbridge Biomedics, Ayoxxa and Entheria. He was most recently director of translation for the Singapore Institute of Neurotechnology, shaping a spinoff company in the medical monitoring space.

Education

• Doctor of Philosophy (Ph.D.) University of California, Berkeley (1996 — 2002)
• B.A. Pitzer College (1987 — 1990)

Companies

• Founder and CEO Incando Therapeutics (2019)
• Adjunct Assistant Professor of Surgery National University of Singapore (2019)
• Head of TN3 Neurodevice Development Group Yong Loo Lin School of Medicine, National University of Singapore (2017 — 2019)
• Head of Research Translation Singapore Institute of Neurotechnology, SINAPSE (2014 — 2017)
• NUS Enterprise National University of Singapore (2010 — 2014)
• Product Development and Marketing Patsnap (2010 — 2011)
• Postdoctoral Fellow Stanford University (2004 — 2009)
• Research Associate Tularik Inc. (1993 — 1996)
• Research Assistant University of Southern California (1990 — 1993)